The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Toxic epidermal necrolysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
A marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Bastuji‐Garin, S. (1993) · Archives of Dermatology · doi:10.1001/archderm.129.1.92 · Cited by 1,697
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284
SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis
Fouchard, N., Bertocchi, M., Roujeau, J.-C., Revuz, J., Wolkenstein, P., & Bastuji-Garin, S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00061.x · Cited by 1,199
Mockenhaupt, M., Viboud, C., Dunant, A., Naldi, L., Halevy, S., Bavinck, J. N. B., Sidoroff, A., Schneck, J., Roujeau, J.-C., & Flahault, A. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701033 · Cited by 1,017
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
McCormack, M., Alfirevic, A., Bourgeois, S., Farrell, J. J., Kasperavičiūtė, D., Carrington, M., Sills, G. J., Marson, T., Jia, X., de Bakker, P. I. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013297 · Cited by 925
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Chung, W.-H., Hung, S.-I., Yang, J.-Y., Su, S.-C., Huang, S.-P., Wei, C.-Y., Chin, S.-W., Chiou, C.-C., Chu, S.-C., Ho, H.-C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1884 · Cited by 840
Acute generalized exanthematous pustulosis (AGEP) – A clinical reaction pattern
Sidoroff, A., Halevy, S., Bavinck, J. N. B., Vaillant, L., & Roujeau, J. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.028003113.x · Cited by 818
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S., Hughes, A. R., Mosteller, M., Shortino, D., Baker, K. L., Spreen, W., Lai, E., Davies, K., Handley, A., Dow, D. J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08158-8 · Cited by 807
Sassolas, B., Haddad, C., Mockenhaupt, M., Dunant, A., Liss, Y., Bork, K., Haustein, U. F., Vieluf, D., Roujeau, J. C., & Le Louet, H. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.252 · Cited by 758
TOXIC EPIDERMAL NECROLYSIS: AN ERUPTION RESEMBLING SCALDING OF THE SKIN.
LYELL, A. (1956) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1956.tb12766.x · Cited by 720
Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
Chen, P., Lin, J.-J., Lu, C.-S., Ong, C.-T., Hsieh, P. F., Yang, C.-C., Tai, C.-T., Wu, S.-L., Lu, C.-H., Hsu, Y.-C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009717 · Cited by 711
Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
Darmon, A. J., Nicholson, D. W., & Bleackley, R. C. (1995) · Nature · doi:10.1038/377446a0 · Cited by 707
Toxic epidermal necrolysis and Stevens-Johnson syndrome
Harr, T., & French, L. E. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-39 · Cited by 693
Lonjou, C., Borot, N., Sekula, P., Ledger, N., Thomas, L., Halevy, S., Naldi, L., Bouwes-Bavinck, J.-N., Sidoroff, A., de Toma, C., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f3ef9c · Cited by 624
Abbott, M. B., & Vlasses, C. H. (2011) · JAMA · doi:10.1001/jama.2011.1775 · Cited by 591
Man, C. B. L., Kwan, P., Baum, L., Yu, E., Lau, K. M., Cheng, A. S. H., & Ng, M. H. L. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01022.x · Cited by 507
Husain, Z., Reddy, B. Y., & Schwartz, R. A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.033 · Cited by 489
Self-citationLocharernkul, C., Loplumlert, J., Limotai, C., Korkij, W., Desudchit, T., Tongkobpetch, S., Kangwanshiratada, O., Hirankarn, N., Suphapeetiporn, K., & Shotelersuk, V. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01719.x · Cited by 482
Sekula, P., Dunant, A., Mockenhaupt, M., Naldi, L., Bouwes Bavinck, J. N., Halevy, S., Kardaun, S., Sidoroff, A., Liss, Y., Schumacher, M., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.510 · Cited by 448
Nitric oxide and its role in apoptosis
Brüne, B., von Knethen, A., & Sandau, K. B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00274-x · Cited by 445
Ferrell, P. B., & McLeod, H. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.10.1543 · Cited by 439
Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
Wolkenstein, P., Latarjet, J., Roujeau, J.-C., Duguet, C., Boudeau, S., Vaillant, L., Maignan, M., Schuhmacher, M.-H., Milpied, B., Pilorget, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02197-7 · Cited by 428
Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
Nassif, A., Bensussan, A., Boumsell, L., Deniaud, A., Moslehi, H., Wolkenstein, P., Bagot, M., & Roujeau, J.-C. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.047 · Cited by 412
Kaniwa, N., Saito, Y., Aihara, M., Matsunaga, K., Tohkin, M., Kurose, K., Sawada, J.-I., Furuya, H., Takahashi, Y., Muramatsu, M., et al. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.11.1617 · Cited by 410
A marker for Stevens-Johnson syndrome …: ethnicity matters
Lonjou, C., Thomas, L., Borot, N., Ledger, N., de Toma, C., LeLouet, H., Graf, E., Schumacher, M., Hovnanian, A., Mockenhaupt, M., et al. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500356 · Cited by 401
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: An Epidemiologic Study From West Germany
Schöpf, E. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680050083008 · Cited by 399
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients
Revuz, J. E. (1987) · Archives of Dermatology · doi:10.1001/archderm.123.9.1160 · Cited by 395
Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985
Roujeau, J. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.1.37 · Cited by 391
HALEBIAN, P. H., CORDER, V. J., MADDEN, M. R., FINKLESTEIN, J. L., & SHIRES, G. T. (1986) · Annals of Surgery · doi:10.1097/00000658-198611000-00001 · Cited by 384
Bachot, N., Revuz, J., & Roujeau, J.-C. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.1.33 · Cited by 380
Pereira, F. A., Mudgil, A. V., & Rosmarin, D. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.04.048 · Cited by 376
Chan, H.-L. (1990) · Archives of Dermatology · doi:10.1001/archderm.1990.01670250049006 · Cited by 371
Rzany, B., Mockenhaupt, M., Baur, S., Schröder, W., Stocker, U., Mueller, J., Holländer, N., Bruppacher, R., & Schöpf, E. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00035-2 · Cited by 355
Rzany, B., Correia, O., Kelly, J. P., Naldi, L., Auquier, A., & Stern, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05418-x · Cited by 348
The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis
Mockenhaupt, M. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.66 · Cited by 347
Chessman, D., Kostenko, L., Lethborg, T., Purcell, A. W., Williamson, N. A., Chen, Z., Kjer-Nielsen, L., Mifsud, N. A., Tait, B. D., Holdsworth, R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.020 · Cited by 334
Idiosyncratic drug reactions: the reactive metabolite syndromes
Knowles, S. R., Uetrecht, J., & Shear, N. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03137-8 · Cited by 331
Prins, C., Kerdel, F. A., Padilla, R. S., Hunziker, T., Chimenti, S., Viard, I., Mauri, D. N., Flynn, K., Trent, J., Margolis, D. J., et al. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.1.26 · Cited by 325
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
Letko, E., Papaliodis, D. N., Papaliodis, G. N., Daoud, Y. J., Ahmed, A. R., & Foster, C. S. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61112-x · Cited by 316
Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis
Nassif, A., Bensussan, A., Bachot, N., Bagot, M., Boumsell, L., Roujeau, J.-C., Dorothée, G., & Mami-Chouaib, F. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01622.x · Cited by 310
Palmieri, T. L., Greenhalgh, D. G., Saffle, J. R., Spence, R. J., Peck, M. D., Jeng, J. C., Mozingo, D. W., Yowler, C. J., Sheridan, R. L., Ahrenholz, D. H., et al. (2002) · The Journal of Burn Care & Rehabilitation · doi:10.1097/00004630-200203000-00004 · Cited by 308
Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
PAUL, C., WOLKENSTEIN, P., ADLE, H., WECHSLER, J., GARCHON, H. J., REVUZ, J., & ROUJEAU, J. C. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb06976.x · Cited by 304
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome Are Induced by Soluble Fas Ligand
Abe, R., Shimizu, T., Shibaki, A., Nakamura, H., Watanabe, H., & Shimizu, H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64284-8 · Cited by 301
Kano, Y., Hirahara, K., Mitsuyama, Y., Takahashi, R., & Shiohara, T. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01553.x · Cited by 276
Valeyrie-Allanore, L., Wolkenstein, P., Brochard, L., Ortonne, N., Maître, B., Revuz, J., Bagot, M., & Roujeau, J. C. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09863.x · Cited by 274
The Culprit Drugs in 87 Cases of Toxic Epidermal Necrolysis (Lyell's Syndrome)
Guillaume, J. C. (1987) · Archives of Dermatology · doi:10.1001/archderm.123.9.1166 · Cited by 257
Guégan, S., Bastuji-Garin, S., Poszepczynska-Guigné, E., Roujeau, J.-C., & Revuz, J. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700068 · Cited by 253
Posadas, S. J., Padial, A., Torres, M. J., Mayorga, C., Leyva, L., Sanchez, E., Alvarez, J., Romano, A., Juarez, C., & Blanca, M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.120563 · Cited by 252
Toxic epidermal necrolysis: current evidence, practical management and future directions
Chave, T. A., Mortimer, N. J., Sladden, M. J., Hall, A. P., & Hutchinson, P. E. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06721.x · Cited by 241
Stevens–Johnson syndrome and toxic epidermal necrolysis
Borchers, A. T., Lee, J. L., Naguwa, S. M., Cheema, G. S., & Gershwin, M. E. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.06.004 · Cited by 224
Huang, Y.-C., Li, Y.-C., & Chen, T.-J. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10965.x · Cited by 223
Treatment of Toxic Epidermal Necrolysis with Cyclosporin A
Ar??valo, J. M., Lorente, J. A., Gonz??lez-Herrada, C., & Jim??nez-Reyes, J. (2000) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200003000-00017 · Cited by 212
Schnyder, B., Burkhart, C., Schnyder-Frutig, K., von Greyerz, S., Naisbitt, D. J., Pirmohamed, M., Park, B. K., & Pichler, W. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6647 · Cited by 211
Biology and clinical relevance of granulysin
Krensky, A. M., & Clayberger, C. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01218.x · Cited by 203
Immune pathomechanism of drug hypersensitivity reactions
Pichler, W. J., Naisbitt, D. J., & Park, B. K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.048 · Cited by 189
Roujeau, J. (1997) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1997.tb02524.x · Cited by 188
DIPASCUALE, M., ESPANA, E., LIU, D., KAWAKITA, T., LI, W., GAO, Y., BARADARANRAFII, A., ELIZONDO, A., RAJU, V, & TSENG, S. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.035 · Cited by 186
Acute disseminated epidermal necrosis types 1, 2, and 3: Study of sixty cases
Ruiz-Maldonado, R. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70207-1 · Cited by 164
Patel, T. K., Barvaliya, M. J., Sharma, D., & Tripathi, C. B. (2013) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.110749 · Cited by 160
Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis
Paquet, P. (1994) · Archives of Dermatology · doi:10.1001/archderm.130.5.605 · Cited by 157
Viard, I., Gaide, O., Jankovic, D. L., Feldmeyer, L., Kerl, K., Pickard, C., Roques, S., Friedmann, P. S., Contassot, E., & French, L. E. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.330 · Cited by 143
Stimulation of human T cells with sulfonamides and sulfonamide metabolites
Castrejón-Flores, J. L., Berry, N. G., El-Ghaiesh, S. H., Gerber, B. O., Pichler, W. J., Park, B. K., & Naisbitt, D. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.031 · Cited by 139
Gregory, D. G. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.046 · Cited by 134
Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis
Egan, C. A., Grant, W. J., Morris, S. E., Saffle, J. R., & Zone, J. J. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70497-4 · Cited by 132
Stevens‐Johnson syndrome: Pathogenesis, diagnosis, and management
Hazin, R., Ibrahimi, O. A., Hazin, M. I., & Kimyai‐Asadi, A. (2008) · Annals of Medicine · doi:10.1080/07853890701753664 · Cited by 131
Yamasaki, O., Yamaguchi, T., Sugai, M., Chapuis‐Cellier, C., Arnaud, F., Vandenesch, F., Étienne, J., & Lina, G. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1890-1893.2005 · Cited by 129
Slatore, C. G., & Tilles, S. A. (2004) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2004.03.011 · Cited by 124
T-Cell Subsets in Drug-Induced Toxic Epidermal Necrolysis
Miyauchi, H. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680050095011 · Cited by 122
Tougeron-Brousseau, B., Delcampe, A., Gueudry, J., Vera, L., Doan, S., Hoang-Xuan, T., & Muraine, M. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.07.006 · Cited by 100
Cartotto, R., Mayich, M., Nickerson, D., & Gómez, M. (2008) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e31815f3865 · Cited by 97
Using a claims database to investigate drug‐induced Stevens‐Johnson syndrome
Strom, B. L., Carson, J. L., Halpern, A. C., Schinnar, R., Snyder, E., Stolley, P. D., Shaw, M., Tilson, H. H., Joseph, M., Dai, W. S., et al. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100408 · Cited by 94
Mycoplasma pneumoniae infections in children.
Stevens, D., Swift, P. G. F., Johnston, P. G. B., Kearney, P. J., Corner, B., & Burman, D. (1978) · Archives of Disease in Childhood · doi:10.1136/adc.53.1.38 · Cited by 90
Ball, R., Ball, L. K., Wise, R. P., Braun, M. M., Beeler, J. A., & Salive, M. E. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00022 · Cited by 84
Immunoregulatory Effector Cells in Drug-Induced Toxic Epidermal Necrolysis
Paquet, P., Paquet, F., Saleh, W. A., Reper, P., Vanderkelen, A., & Pierard, G. (2000) · American Journal of Dermatopathology · doi:10.1097/00000372-200010000-00005 · Cited by 83
Narita, Y. M., Hirahara, K., Mizukawa, Y., et al. (2011) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2010.01154.x · Cited by 76
Kashiwagi, M., Aihara, M., Takahashi, Y., YAMAZAKI, E., YAMANE, Y., Song, Y., Muramatsu, M., & Ikezawa, Z. (2008) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2008.00548.x · Cited by 75
Stur, K., Karlhofer, F. M., & Stingl, G. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700648 · Cited by 75
Acute Renal Failure and Its Risk Factors in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Hung, C., Liu, W., Kuo, M., Lee, C., Hwang, S., & Chen, H. (2009) · American Journal of Nephrology · doi:10.1159/000195632 · Cited by 63
Zhu, Q., Ma, L., Luo, X., & Huang, H.-Y. (2012) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e318254d2ec · Cited by 63
Nitric Oxide Synthase in Toxic Epidermal Necrolysis and Stevens–Johnson Syndrome
Lerner, L. H., Qureshi, A. A., Reddy, B. V., & Lerner, E. A. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00816.x · Cited by 62
Drug-Induced Linear IgA Bullous Dermatosis
Onodera, H., Mihm, M. C., Yoshida, A., & Akasaka, T. (2005) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2005.tb00839.x · Cited by 58
Caproni, M., Torchia, D., Schincaglia, E., Volpi, W., Frezzolini, A., Schena, D., Marzano, A. V., Quaglino, P., SIMONE, C. D., Parodi, A., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07023.x · Cited by 58
Paquet, P., & Pierard, G. (2010) · Drug Safety · doi:10.2165/11532540-000000000-00000 · Cited by 56
Engler, O. B., Strasser, I., Naisbitt, D. J., Cerny, A., & Pichler, W. J. (2004) · Toxicology · doi:10.1016/j.tox.2003.12.008 · Cited by 54
Novel Treatments for Drug-Induced Toxic Epidermal Necrolysis (Lyell’s Syndrome)
Paquet, P., Pierard, G., & Quatresooz, P. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000083947 · Cited by 52
Nakajima, S. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.239 · Cited by 47
Tohyama, M., Watanabe, H., Murakami, S., Shirakata, Y., Sayama, K., Iijima, M., & Hashimoto, K. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10649.x · Cited by 43
Chapman, A. D. S., Williams, G., Soni, N., & Bunker, C. B. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09585.x · Cited by 41
Morel, E., Álvarez, L., Cabañas, R., Fiandor, A. M., Díaz, R., Escamochero, S., Prior, N., Blanca, M., & Bellón, T. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02484.x · Cited by 39
Toxic epidermal necrolysis following morbilli‐parotitis‐rubella vaccination
Dobrosavljević, D., Milinkovic, M. V., & Nikolic, M. M. (1999) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.1999.tb00846.x · Cited by 33
Marzano, A. V., Frezzolini, A., Caproni, M., et al. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000313 · Cited by 24
Cutaneous graft-versus-host disease: rationales and treatment options
Chavan, R. N., & el‐Azhary, R. A. (2011) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2011.01397.x · Cited by 23
Paquet, P., & Pierard, G. (2006) · Skin Pharmacology and Physiology · doi:10.1159/000097652 · Cited by 23
Vancomycin-induced linear IgA bullous dermatosis: morphology is a key to diagnosis.
Solky, B. A., Pincus, L. B., & Horan, R. F. (2004) · PubMed · Cited by 19
Morelli, J. G. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00637-0 · Cited by 1
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature
Casagranda, A., Suppa, M., Dehavay, F., & del Marmol, V. (2017) · Case Reports in Dermatology · doi:10.1159/000475802 · Cited by 1,466
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Metadata
- Authors
- Schwartz, R. A., McDonough, P. H., & Lee, B. W.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 69
- Issue
- 2
- Pages
- 187.e1-187.e16
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2765971926
- Cited by
- 338
- References
- 102
- FWCI
- 23.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.